The Valley Desk

Clinical trial reportClinical and experimental dermatologyPublished

Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical and experimental dermatology
Published
Subject terms
Humans; Ichthyosis; Ichthyosiform Erythroderma, Congenital; Ichthyosis, Lamellar; Ichthyosis, X-Linked; Isotretinoin; Immunoglobulin A; Adult
PubMed ID
36794376
Added to directory
Source checked

Report a correction or request removal